Work for Tricida, Inc.?

Claim Your Profile

Tricida, Inc. Logo Image

Tricida, Inc.

Tricida, Inc. Banner Image

About Tricida, Inc.

51-200 Employees
Based in South San Francisco, California

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting the VALOR-CKD clinical trial to evaluate the efficacy and safety of veverimer in delaying CKD progression in subjects with metabolic acidosis. There are no FDA-approved treatments for chronic metabolic acidosis.

Ticker:
TCDA
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Major (See More Drug Manufacturers - Major Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol